Page History

The procedures (PR) domain contains interventional activity intended to have diagnostic, preventive, therapeutic, or palliative effects. The example PR dataset below shows the cardiac magnetic resonance imaging with two different MRI machines (PRTRT=MRI and PRLOC=HEART). The sponsor device identifier (SPDEVID) variable is used to represent the imaging device identifier information provided in the DI dataset below.

Dataset wrap

Name	pr

Rowcaps

Row 1:	Shows the results of a cardiac MRI for participant DMD-LGE-01-201.
Row 2:	Shows the results of a cardiac MRI for participant DMD-LGE-01-202 with a different MRI machine. The time of the procedure was not available so only the date is shown in the PRSTDTC variable.

Dataset2

Row	STUDYID	DOMAIN	USUBJID	PRSEQ	SPDEVID	PRREFID	PRLNKID	PRTRT	PRLOC	PRFAST	PRSTDTC
1	DMD-EFLGE	PR	DMD-LGE-01-201	1	ABC001	12345678	04	MRI	HEARTCARDIAC MAGNETIC RESONANCE IMAGING	Y	2023-07-01T09:15:00
2	DMD-EFLGE	PR	DMD-LGE-01-202	1	ABC002	98765432	05	MRI	HEARTCARDIAC MAGNETIC RESONANCE IMAGING	N	2023-07-05

The example CV dataset below shows the results of the LGE test measured using CMR imaging. The analysis method describes the method of secondary processing applied to a complex observation result (e.g., an image, a genetic sequence). There may be machine-centric analysis methods inherit to the type of machine (e.g., full-width half maximum, 5 standard deviations, 6 standard deviations). (Ref: https://jcmr-online.biomedcentral.com/articles/10.1186/1532-429X-12-21). If this information is of interest to the study, it would be represented using the CVANMETH variable.

Dataset wrap

Name	cv

Rowcaps

Row 1:	Shows that LGE is positive for participant DMD-LGE-01-201.
Row 2:	Shows the total LGE percentage is 40%.
Rows 3-19:	Show the segmental LGE results for each of the left ventricle segments.
Row 20:	Shows the LGE segment count.
Rows 21-24:	Show the segmental LGE percentage for each of the positive segments.
Row 25:	Shows that LGE is negative for participant DMD-LGE-01-202.

Dataset2

Row	STUDYID	DOMAIN	USUBJID	CVSEQ	CVLNKID	CVTESTCD	CVTEST	CVORRES	CVORRESU	CVSTRESC	CVSTRESN	CVSTRESU	CVLOC	CVMETHOD	CVANMETH	VISITNUM	VISIT	CVDTC
1	DMD-EFLGE	CV	DMD-LGE-01-201	1	04	LGE	LATE GADOLINIUM ENHANCEMENT	POSITIVE		POSITIVE			HEART, LEFT VENTRICLE	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
2	DMD-EFLGE	CV	DMD-LGE-01-201	2	04	LGEPER	LATE GADOLINIUM ENHANCEMENT PERCENTAGE	40	%	40	40	%	HEART, LEFT VENTRICLE	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	QUANTITATIVE	1	VISIT 1	2023-07-01
3	DMD-EFLGE	CV	DMD-LGE-01-201	3	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	NEGATIVE		NEGATIVE			LEFT VENTRICULAR BASAL ANTERIOR SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
4	DMD-EFLGE	CV	DMD-LGE-01-201	4	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	POSITIVE		POSITIVE			LEFT VENTRICULAR BASAL ANTEROLATERAL SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
5	DMD-EFLGE	CV	DMD-LGE-01-201	5	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	POSITIVE		POSITIVE			LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
6	DMD-EFLGE	CV	DMD-LGE-01-201	6	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	NEGATIVE		NEGATIVE			LEFT VENTRICULAR BASAL INFERIOR SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
7	DMD-EFLGE	CV	DMD-LGE-01-201	7	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	NEGATIVE		NEGATIVE			LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
8	DMD-EFLGE	CV	DMD-LGE-01-201	8	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	NEGATIVE		NEGATIVE			LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
9	DMD-EFLGE	CV	DMD-LGE-01-201	9	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	NEGATIVE		NEGATIVE			LEFT VENTRICULAR MID ANTERIOR SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
10	DMD-EFLGE	CV	DMD-LGE-01-201	10	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	POSITIVE		POSITIVE			LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
11	DMD-EFLGE	CV	DMD-LGE-01-201	11	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	POSITIVE		POSITIVE			LEFT VENTRICULAR MID INFEROSEPTAL SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
12	DMD-EFLGE	CV	DMD-LGE-01-201	12	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	NEGATIVE		NEGATIVE			LEFT VENTRICULAR MID INFERIOR SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
13	DMD-EFLGE	CV	DMD-LGE-01-201	13	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	NEGATIVE		NEGATIVE			LEFT VENTRICULAR MID INFEROLATERAL SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
14	DMD-EFLGE	CV	DMD-LGE-01-201	14	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	NEGATIVE		NEGATIVE			LEFT VENTRICULAR MID ANTEROLATERAL SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
15	DMD-EFLGE	CV	DMD-LGE-01-201	15	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	NEGATIVE		NEGATIVE			LEFT VENTRICULAR APICAL ANTERIOR SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
16	DMD-EFLGE	CV	DMD-LGE-01-201	16	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	NEGATIVE		NEGATIVE			LEFT VENTRICULAR APICAL SEPTAL SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
17	DMD-EFLGE	CV	DMD-LGE-01-201	17	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	NEGATIVE		NEGATIVE			LEFT VENTRICULAR APICAL INFERIOR SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
18	DMD-EFLGE	CV	DMD-LGE-01-201	18	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	NEGATIVE		NEGATIVE			LEFT VENTRICULAR APICAL LATERAL SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
19	DMD-EFLGE	CV	DMD-LGE-01-201	19	04	SGELGE	SEGMENTAL LATE GADOLINIUM ENHANCEMENT	NEGATIVE		NEGATIVE			LEFT VENTRICULAR APEX SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
20	DMD-EFLGE	CV	DMD-LGE-01-201	20	04	LGESEGCT	LATE GADOLINIUM ENHANCEMENT SEGMENT CT	4		4	4		HEART, LEFT VENTRICLE	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-01
21	DMD-EFLGE	CV	DMD-LGE-01-201	21	04	LGEPER	LATE GADOLINIUM ENHANCEMENT PERCENTAGE	40	%	40	40	%	LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	FULL-WIDTH HALF MAXIMUM	1	VISIT 1	2023-07-01
22	DMD-EFLGE	CV	DMD-LGE-01-201	22	04	LGEPER	LATE GADOLINIUM ENHANCEMENT PERCENTAGE	20	%	20	20	%	LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	FULL-WIDTH HALF MAXIMUM	1	VISIT 1	2023-07-01
23	DMD-EFLGE	CV	DMD-LGE-01-201	23	04	LGEPER	LATE GADOLINIUM ENHANCEMENT PERCENTAGE	45	%	45	45	%	LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	FULL-WIDTH HALF MAXIMUM	1	VISIT 1	2023-07-01
24	DMD-EFLGE	CV	DMD-LGE-01-201	24	04	LGEPER	LATE GADOLINIUM ENHANCEMENT PERCENTAGE	20	%	20	20	%	LEFT VENTRICULAR INFEROSEPTAL SEGMENT	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	FULL-WIDTH HALF MAXIMUM	1	VISIT 1	2023-07-01
25	DMD-EFLGE	CV	DMD-LGE-01-202	1	05	LGE	LATE GADOLINIUM ENHANCEMENT	NEGATIVE		NEGATIVE			HEART, LEFT VENTRICLE	CARDIAC MAGNETIC RESONANCE IMAGINGMRI	VISUAL	1	VISIT 1	2023-07-05

The procedure agents (AG) domain contains the agents administered to the subject as part of a procedure or assessment. The example AG dataset below shows the timing of the gadolinium-based contrast, 'Gd-DOTA'. The time the contrast was given to participant DMD-LGE-01-202 was not available, so only the date is represented in AGSTDTC variable.

...

Space shortcuts

Page tree

Versions Compared

Old Version 72

New Version 73

Key